July 6, 2016
I am excited to share with you more encouraging news out of Washington, D.C. Today, the House Labor-HHS Appropriations Subcommittee announced a $350 million increase for Alzheimer’s disease research at the National Institutes of Health (NIH). This comes just a few weeks after I was able to share with you the historic news that the Senate Appropriations Committee approved a $400 million increase.
With this proposed increase, both the House and the Senate have now proposed increases that are $50 million above what they proposed last summer. We are confident that, just like last year, our champions in the House and Senate will work hard to deliver the best possible final increase that they can, starting from these two proposals.
We will keep you informed, as the appropriations process continues to unfold. As you will likely recall, in June 2015 we were thrilled to share news of the historic $350 million increase, which was ultimately signed into law in December 2015 for FY2016.
It was just five years ago when Alzheimer's disease research funding at the NIH stood at only $448 million per year. With last year’s historic action Alzheimer’s disease research funding reached $991 million for the FY2016 budget. If another step of this magnitude is signed into law, we will surpass the $1.3 billion mark.
We are very proud of and thankful to our partners.This monumental growth would not have happened without your tireless work and support of of the Alzheimer's Association and the Alzheimer's Impact Movement. Working together going forward, we will accomplish even more, as we succeed in delivering our mission and in realizing our vision even sooner.